Sign Up to like & get
recommendations!
1
Published in 2022 at "Australasian Journal of Dermatology"
DOI: 10.1111/ajd.13799
Abstract: Pemigatinib is a Fibroblast grow factor receptor (FGFR) inhibitor used since 2020 as a second line in cholangiocarcinomas and advanced urothelial carcinomas. Dermatological adverse effects, like nail toxicity, have been reported in the phase 2…
read more here.
Keywords:
scar sarcoidosis;
secukinumab induced;
dermatology;
patient ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2021 at "Journal of the European Academy of Dermatology and Venereology"
DOI: 10.1111/jdv.17286
Abstract: Diverse cutaneous manifestations of Coronavirus disease-2019 (Covid-19) have been reported including morbilliform, pernio-like, urticarial, vesicular, and papulosquamous eruptions.1 In the context of association between Covid-19 and sarcoidal granulomas, only one case of sarcoid-like granulomatous subcutaneous…
read more here.
Keywords:
scar sarcoidosis;
mimicking scar;
sarcoidal granulomas;
covid ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2022 at "Annals of Dermatology"
DOI: 10.5021/ad.2022.34.1.28
Abstract: Background Scar sarcoidosis (SS), a rare form of cutaneous sarcoidosis, develops from pre-existing scars. Owing to its rarity, the clinicopathologic features and its significance in clinical prognosis have been obscure. Objective This study aimed to…
read more here.
Keywords:
scar;
scar sarcoidosis;
systemic involvement;
latent period ... See more keywords